Skip to content

Determination of the MLAD of ropivacaine in real-time ultrasound guided spinal anesthesia for cesarean section

Determination of MLAD of ropivacaine in real-time ultrasound guided spinal anesthesia for cesarean section

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079509
Enrollment
Unknown
Registered
2024-01-04
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

24-gauge spinal needle USRTG group:Real-time ultrasound-guided 24G spinal needle puncture
26-gauge spinal needle USRTG group:Real-time ultrasound-guided 26G spinal needle puncture

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. ASA II-III grade; 3. Patients diagnosed with cesarean section; 4. Voluntarily and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Intraspinal anesthesia is contraindicated; 2. After spinal deformity or spinal surgery; 3. Infection at the puncture site; 4. Local anesthetic allergy; 5. Coagulation disorders; 6. Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Time for sensory block to reach T6 level;the time sensory blockade above T6 level and the highest level;Onset time of motor block;Duration of motor retardation;Doses;

Secondary

MeasureTime frame
Visual Analogue Scale score of surgery process;The using time of operation;Postoperatie resting and motion Visual Analogue Scale scores;Clinical data;Postoperative complications;Complications of intraspinal puncture;The time first out of bed;Patient satisfaction;Puncture use time;Hospital stay;Neonatal Apgar score;

Countries

China

Contacts

Public ContactTing Zheng

Department of Anesthesiology, Fujian Provincial Hospital

zhengting1223@163.com+86 156 5911 5373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026